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Background: Neovascularization is an attractive therapeutic option for PAD, since the role of surgical revascularization is limited to patients with 
good distal targets. H2S is a gaseous signaling molecule which has endothelial cell proliferation and anti-inflammatory effects. So far there is no 
sulfide donor that is biochemically stable to have practical implication in clinical therapeutics. Here, we examined the effect of diallyl trisulfide on 
tissue and plasma sulfide levels and its effect on arteriogenesis in the setting of murine permanent hind limb ischemia.
Hypothesis: Diallyl trisulfide is a stable and potent H2S donor causing sustained elevation in biological H2S levels that would efficiently augment 
ischemic arteriogenesis in murine critical limb ischemia.
Methods: Hind limb ischemia was induced in C57BL/6J wild type mice by permanent ligation and excision of the left femoral artery. Mice were 
randomly assigned to four experimental groups (n=5); PBS, DATS at 100mcg/kg, 200mcg/kg and 500mcg/kg. Study drug was administered twice 
daily by retro-orbital injection until day 21. Hind limb blood perfusion measurement was performed by laser Doppler. Arteriogenesis index was 
measured by the ratio of alpha-SMA positive / DAPI positive vessels. Plasma sulfide levels were measured by HPLC using MBB, pre-injection of DATS/
PBS and every 15 minutes thereafter until one hour.
Results: By day 21, blood flow in left limb was significantly increased in DATS group in a dose response manner compared to minimal response in PBS 
group. Blood flows were 64.1 ± 2.08 with PBS, 101 ± 5.5 with 100mcg/kg DATS, 115.2 + 3.5 with 200mcg/kg and 108 + 1.3 with 500mcg/kg by day 
21. There was significantly higher arterial density as shown by alpha-SMA/DAPI ratio of 0.7 + 0.07 with 200mcg/kg DATS compared to 0.2 + 0.04 with 
PBS. There was sustained elevation of plasma hydrogen sulfide levels one hour after a single 200mcg/kg injection of DATS compared to PBS.
Conclusions: DATS is a stable H2S donor providing sustained plasma hydrogen sulfide levels effective in augmenting ischemic hind limb blood 
flow. This molecule could serve a critical role in relieving tissue ischemia through neovascularization in peripheral arterial disease.
